Genetic prion diseases presenting as frontotemporal lobar degeneration: clinical features and diagnostic challenge

نویسندگان

چکیده

Background Elucidate the clinical and ancillary feature of genetic prion diseases (gPrDs) presenting with frontotemporal lobar degeneration (FTLD) in order to aid early identification, diagnosis, referral for genotype testing. Method Global data gPrDs FTLD caused by protein gene (PRNP) mutations were collected from literature review our records. Fifty-one cases typical 136 admitted institution included as controls. Clinical different groups compared. Result Forty-nine identified, 23 which female. Twenty-three PRNP have been reported be associated FTLD, P39L being most commonly reported, seen 4 families 5 cases. Compared or diseases, is characterized earlier onset age (median: 45 vs. 61/60 years) stronger family history (81.6% 27.5/13.2%). In addition, exhibited shorter duration 8 years), a higher rate features compared FTLD. had longer symptoms 1.1 rates atrophy (89.7% 3.3%), lower periodic short-wave complexes on EEG (0% 29.4%), hyperintensity MRI (25.0% 83.0%). The frequency Val allele codon 129 carriers was significantly than that (33.3% 19.2%). Conclusion GPrDs early-onset, strong history, high PRNP. intermediate two distinct conditions, while auxiliary closer Patients these characteristics need considered

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.

OBJECTIVE To assess the relative frequency of unique mutations and their associated characteristics in 97 individuals with mutations in progranulin (GRN), an important cause of frontotemporal lobar degeneration (FTLD). PARTICIPANTS AND DESIGN A 46-site International Frontotemporal Lobar Degeneration Collaboration was formed to collect cases of FTLD with TAR DNA-binding protein of 43-kDa (TDP-...

متن کامل

Frontotemporal lobar degeneration: a clinical approach.

In this review, the authors outline a clinical approach to frontotemporal lobar degeneration (FTLD), a term coined to describe a pathology associated with atrophy of the frontal and temporal lobes commonly seen with abnormal protein aggregates. It accounts for ∼10% of pathologically confirmed dementias. The three clinical syndromes associated with FTLD are jointly classified as frontotemporal d...

متن کامل

[Frontotemporal lobar degeneration].

Article abstract-Objectiue: To improve clinical recognition and provide research diagnostic criteria for three clinical syndromes associated with frontotemporal lobar degeneration. Methods: Consensus criteria for the three prototypic syndromes-frontotemporal dementia, progressive nonfluent aphasia, and semantic dementia-were developed by members of an international workshop on frontotemporal lo...

متن کامل

Unpicking frontotemporal lobar degeneration.

Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130–3. Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR. Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology 2009; 72: 732–7. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensit...

متن کامل

Frontotemporal Lobar Degeneration

Frontotemporal lobar degeneration (FTLD) comprises diseases with a very diverging spectrum in regards to clinical presentation, genetics, and neuropathology. In 1892 Arnold Pick published the case of 71-year old male with progressive symptoms of aphasia, apathy, and dementia (Pick 1892). The pathological examination revealed cortical atrophy with emphasis on the left temporal lobe (Pick 1892). ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Alzheimers & Dementia

سال: 2023

ISSN: ['1552-5260', '1552-5279']

DOI: https://doi.org/10.1002/alz.061751